Table 3

14C-d-xylose and lactulose breath tests, endotoxin levels, intestinal permeability, tumour necrosis factor α (TNF-α) levels, small intestinal transit times, and diabetes prevalence for control subjects

Patient No14C-d-xylose + lactulose breath testEndotoxin (EU/ml)Intestinal permeability (L/R ratio)TNF-α (pg/ml)Small intestinal transit time (minutes)Diabetes (yes/no/gi)
1Negative1.24.7120No
2Positive1.40.0616.2120No
3Negative1.50.040.4150No
4Negative1.40.159.7240No
5Positive1.410.8270No
6Negative1.20.4514.7150No
7Positive1.20.047.3180Yes
8Negative1.20.1090No
9Negative1.10.126.6240No
10Negative1.34.7No
11Negative1.30.187.3240No
12Negative1.00.083.1180No
13Negative1.28.1150No
14Negative1.50.067.3No
15Negative1.39.3240No
16Negative1.114.3No
17Negative2.00.165.4No
18Negative1.75.8120No
19Negative0.90.186.6No
20Negative1.30.086.2No
21Positive1.20.113.5210No
22Negative1.50.126.6No
23Positive1.10.155.8180No
Mean (SD)1.3 (0.2)0.13 (0.09)7.5  (3.8)180  (53)
  • gi, glucose intolerance.